B-Cell Non-Hodgkin Lymphoma Pipeline Insights, 2019 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 28, 2019--The “B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.
“B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across B-Cell Non-Hodgkin Lymphoma development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active B-Cell Non-Hodgkin Lymphoma pipeline products by developmental stage, product type, molecule type, and administration route.
Key Topics Covered:
1. Report Introduction
2. B-Cell Non-Hodgkin Lymphoma Overview
3. Pipeline TherapeuticsAn Overview of Pipeline Products for B-Cell Non-Hodgkin Lymphoma
4. Comparative Analysis
5. Products in Clinical StageProduct Description Research and Development Product Development Activities
6. Products in Pre-Clinical and Discovery StageProduct Description Research and Development Product Development Activities
7. Therapeutic AssessmentAssessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type
8. Inactive ProductsProduct Description Research and Development Product Development Activities
Companies MentionedGilead Sciences Pfizer CTI BioPharma Shanghai Henlius Biotech MorphoSys AG Amgen Janssen Research & Development LLC Mabion SA Celgene TG Therapeutics Inc. Sinocelltech Ltd. Innovent Biologics (Suzhou) Co. Ltd. Mundipharma Research Limited Biocad ImmunoGen Inc Karyopharm Therapeutics Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/mhnb7v/bcell?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190128005391/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Lymphoma Drugs
KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/28/2019 09:38 AM/DISC: 01/28/2019 09:38 AM